The Optimal Balance between Oncolytic Viruses and Natural Killer Cells: A Mathematical Approach

Oncolytic virotherapy (OV) is a cancer therapy utilizing lytic viruses that specifically target cancer cells for elimination. In this relatively new therapy, two contradictory observations have been made. Some studies showed that immune responses including activated natural killer (NK) cells post on...

Full description

Saved in:
Bibliographic Details
Published inMathematics (Basel) Vol. 10; no. 18; p. 3370
Main Authors Kim, Dongwook, Shin, Dong-Hoon, Sung, Chang K
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 01.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Oncolytic virotherapy (OV) is a cancer therapy utilizing lytic viruses that specifically target cancer cells for elimination. In this relatively new therapy, two contradictory observations have been made. Some studies showed that immune responses including activated natural killer (NK) cells post oncolytic viral infection increased the cancer cell death, while others reported that such initial immune responses diminished the anti-tumor efficacy, which was caused by premature viral clearance. In this paper, we present a mathematical model to investigate the effect of NK cells on oncolytic virotherapy. Particularly, we focused on the minimum condition for NK cells to be activated in terms of parameters and how the activation of NK cells interacts and changes the dynamics among cancer, infected cancer cells and oncolytic virus. Analytic works for the existence and stability conditions of equilibrium points are provided. Numerical results are in good agreement with analytic solutions. Our numerical results show that equilibrium points can be created or destroyed by the activation of NK cells in a dynamical system and suggest that the balance between the bursting rate of the virus and the activation rate of NK cells is a crucial factor for successful OV therapy.
AbstractList Oncolytic virotherapy (OV) is a cancer therapy utilizing lytic viruses that specifically target cancer cells for elimination. In this relatively new therapy, two contradictory observations have been made. Some studies showed that immune responses including activated natural killer (NK) cells post oncolytic viral infection increased the cancer cell death, while others reported that such initial immune responses diminished the anti-tumor efficacy, which was caused by premature viral clearance. In this paper, we present a mathematical model to investigate the effect of NK cells on oncolytic virotherapy. Particularly, we focused on the minimum condition for NK cells to be activated in terms of parameters and how the activation of NK cells interacts and changes the dynamics among cancer, infected cancer cells and oncolytic virus. Analytic works for the existence and stability conditions of equilibrium points are provided. Numerical results are in good agreement with analytic solutions. Our numerical results show that equilibrium points can be created or destroyed by the activation of NK cells in a dynamical system and suggest that the balance between the bursting rate of the virus and the activation rate of NK cells is a crucial factor for successful OV therapy.
Audience Academic
Author Sung, Chang K
Kim, Dongwook
Shin, Dong-Hoon
Author_xml – sequence: 1
  fullname: Kim, Dongwook
– sequence: 2
  fullname: Shin, Dong-Hoon
– sequence: 3
  fullname: Sung, Chang K
BookMark eNptUcFuEzEQtVCRKKU3PsASV1Ls9Xq95haiQisKuRSu1tgeN46cdbA3Qv173AZBkRgfxpp58_Se3ktyMuUJCXnN2YUQmr3bwbzhjI9CKPaMnHZdpxaqLU6e_F-Q81q3rJXmYuz1KTG3G6Tr_Rx3kOgHSDA5pBbnn4gTXU8up_s5Ovo9lkPFSmHy9CvMh9LQn2NKWOgKU6rv6ZJ-aQKwqYiuLZf7fcngNq_I8wCp4vnvfka-fby8XV0tbtafrlfLm4XrRT8vQID1XmmuOi1hcMpr50ZnkTGvRh_UEKR0VjI7WN4pYaWXAkWHWmmvxCjOyPWR12fYmn1pfsq9yRDN4yCXOwOlSUtopAvDYEEp3g-9RT2iH0HwAAML3AJvXG-OXM3CjwPW2WzzoUxNvukUH6TigrO_qDtopHEKeS7gdrE6s1R9r6SQ-gF18R9Uex530bUEQ2zzfw7eHg9cybUWDH_McGYegjZPgxa_AGk7myY
CitedBy_id crossref_primary_10_3390_v15091812
crossref_primary_10_3390_vaccines12070721
crossref_primary_10_1016_j_compbiomed_2023_107362
Cites_doi 10.1038/cgt.2008.74
10.3934/mbe.2011.8.841
10.1155/2017/6587258
10.1016/j.jtbi.2015.04.004
10.1038/s41598-019-57240-x
10.1172/JCI32727
10.11594/jtls.07.01.03
10.3390/v13081570
10.1080/21645515.2020.1723363
10.3389/fonc.2017.00106
10.1056/NEJMoa1716435
10.3390/cancers13061383
10.3390/v13081450
10.1038/nri2448
10.1158/1535-7163.MCT-05-0334
10.1073/pnas.1715295115
10.1186/s13662-020-02893-6
10.3389/fimmu.2020.00683
10.1016/j.omtm.2020.01.001
10.1038/nm.3013
10.1089/104303403321070847
10.1038/mt.2011.276
10.3389/fonc.2020.00702
10.1016/j.semcancer.2021.05.013
10.1007/s11538-021-00903-6
10.1158/0008-5472.CAN-04-3227
10.1016/j.omto.2020.02.001
10.1158/0008-5472.CAN-05-2661
10.3390/cancers10100356
10.1158/1078-0432.CCR-16-0477
ContentType Journal Article
Copyright COPYRIGHT 2022 MDPI AG
2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2022 MDPI AG
– notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
3V.
7SC
7TB
7XB
8AL
8FD
8FE
8FG
8FK
ABJCF
ABUWG
AFKRA
ARAPS
AZQEC
BENPR
BGLVJ
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
JQ2
K7-
KR7
L6V
L7M
L~C
L~D
M0N
M7S
P62
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PTHSS
Q9U
DOA
DOI 10.3390/math10183370
DatabaseName CrossRef
ProQuest Central (Corporate)
Computer and Information Systems Abstracts
Mechanical & Transportation Engineering Abstracts
ProQuest Central (purchase pre-March 2016)
Computing Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Database (Proquest)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Database‎ (1962 - current)
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
Technology Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Computer Science Collection
Computer Science Database
Civil Engineering Abstracts
ProQuest Engineering Collection
Advanced Technologies Database with Aerospace
Computer and Information Systems Abstracts – Academic
Computer and Information Systems Abstracts Professional
Computing Database
Engineering Database
ProQuest Advanced Technologies & Aerospace Collection
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
ProQuest Central Basic
Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Computer Science Database
ProQuest Central Student
Technology Collection
Technology Research Database
Computer and Information Systems Abstracts – Academic
Mechanical & Transportation Engineering Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Computer Science Collection
Computer and Information Systems Abstracts
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Central China
ProQuest Central
ProQuest Engineering Collection
ProQuest Central Korea
Advanced Technologies Database with Aerospace
Engineering Collection
Advanced Technologies & Aerospace Collection
Civil Engineering Abstracts
ProQuest Computing
Engineering Database
ProQuest Central Basic
ProQuest Computing (Alumni Edition)
ProQuest One Academic Eastern Edition
ProQuest Technology Collection
ProQuest SciTech Collection
Computer and Information Systems Abstracts Professional
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList CrossRef

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Mathematics
EISSN 2227-7390
ExternalDocumentID oai_doaj_org_article_5cf66ba771464be98ed8a31fa60f1ba1
A744753590
10_3390_math10183370
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID -~X
3V.
5VS
85S
8FE
8FG
AADQD
AAFWJ
AAYXX
ABDBF
ABJCF
ABJNI
ABPPZ
ABUWG
ACIPV
ACIWK
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
ARAPS
AZQEC
BCNDV
BENPR
BGLVJ
BPHCQ
CCPQU
CITATION
DWQXO
GNUQQ
GROUPED_DOAJ
HCIFZ
IAO
ITC
K6V
K7-
KQ8
L6V
M0N
M7S
MODMG
M~E
OK1
PIMPY
PQQKQ
PROAC
PTHSS
RNS
7SC
7TB
7XB
8AL
8FD
8FK
FR3
JQ2
KR7
L7M
L~C
L~D
P62
PQEST
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-c434t-a3abdd7917295a6c7d9cc8cbe00d78df76f55cb50b6b1273b5d53e32e979d7383
IEDL.DBID DOA
ISSN 2227-7390
IngestDate Tue Oct 22 15:16:12 EDT 2024
Thu Oct 10 19:09:17 EDT 2024
Wed Jun 26 19:16:20 EDT 2024
Tue Jun 25 19:20:43 EDT 2024
Thu Sep 26 20:55:57 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c434t-a3abdd7917295a6c7d9cc8cbe00d78df76f55cb50b6b1273b5d53e32e979d7383
ORCID 0000-0002-1178-3720
0000-0001-7746-3570
OpenAccessLink https://doaj.org/article/5cf66ba771464be98ed8a31fa60f1ba1
PQID 2716571310
PQPubID 2032364
ParticipantIDs doaj_primary_oai_doaj_org_article_5cf66ba771464be98ed8a31fa60f1ba1
proquest_journals_2716571310
gale_infotracmisc_A744753590
gale_infotracacademiconefile_A744753590
crossref_primary_10_3390_math10183370
PublicationCentury 2000
PublicationDate 2022-09-01
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Mathematics (Basel)
PublicationYear 2022
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References Yu (ref_17) 2012; 18
Huang (ref_2) 2020; 30
Desjardins (ref_9) 2018; 379
Friedman (ref_27) 2006; 66
Mosser (ref_32) 2008; 8
Ikawati (ref_24) 2016; 7
ref_31
ref_30
Franco (ref_15) 2020; 17
Altomonte (ref_19) 2009; 16
Senekal (ref_26) 2021; 83
Shi (ref_12) 2020; 11
Li (ref_14) 2017; 23
ref_16
Tian (ref_29) 2011; 8
Leung (ref_13) 2020; 16
Filley (ref_10) 2017; 7
Han (ref_18) 2015; 5
Simbawa (ref_11) 2020; 2020
Kim (ref_20) 2018; 115
Macnamara (ref_22) 2015; 377
Wodarz (ref_25) 2003; 14
Gesundheit (ref_8) 2020; 10
Thorne (ref_5) 2007; 117
Kambara (ref_28) 2005; 65
ref_3
Mondal (ref_4) 2020; 16
Phan (ref_23) 2017; 2017
ref_7
Parato (ref_1) 2012; 20
ref_6
Mahasa (ref_21) 2020; 10
Komarova (ref_33) 2006; 5
References_xml – ident: ref_30
– volume: 16
  start-page: 266
  year: 2009
  ident: ref_19
  article-title: Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
  publication-title: Cancer Gene Ther.
  doi: 10.1038/cgt.2008.74
  contributor:
    fullname: Altomonte
– volume: 8
  start-page: 841
  year: 2011
  ident: ref_29
  article-title: The replicability of oncolytic virus: Defining conditions in tumor virotherapy
  publication-title: Math. Biosci. Eng.
  doi: 10.3934/mbe.2011.8.841
  contributor:
    fullname: Tian
– volume: 2017
  start-page: 6587258
  year: 2017
  ident: ref_23
  article-title: The Role of the Innate Immune System in Oncolytic Virotherapy
  publication-title: Comput. Math. Methods Med.
  doi: 10.1155/2017/6587258
  contributor:
    fullname: Phan
– volume: 30
  start-page: 39
  year: 2020
  ident: ref_2
  article-title: Oncolytic therapy and gene therapy for cancer: Recent advances in antitumor effects of Newcastle disease virus
  publication-title: Discov. Med.
  contributor:
    fullname: Huang
– volume: 377
  start-page: 1
  year: 2015
  ident: ref_22
  article-title: Memory versus effector immune responses in oncolytic virotherapies
  publication-title: J. Theor. Biol.
  doi: 10.1016/j.jtbi.2015.04.004
  contributor:
    fullname: Macnamara
– volume: 10
  start-page: 425
  year: 2020
  ident: ref_21
  article-title: Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-57240-x
  contributor:
    fullname: Mahasa
– volume: 117
  start-page: 3350
  year: 2007
  ident: ref_5
  article-title: Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI32727
  contributor:
    fullname: Thorne
– volume: 7
  start-page: 16
  year: 2016
  ident: ref_24
  article-title: A Dynamical Analysis on a Tumour Virotherapy Model with Standard Incident Rate
  publication-title: J. Trop. Life Sci.
  doi: 10.11594/jtls.07.01.03
  contributor:
    fullname: Ikawati
– volume: 5
  start-page: 945
  year: 2015
  ident: ref_18
  article-title: TGF-beta signaling and its targeting for glioma treatment
  publication-title: Am. J. Cancer Res.
  contributor:
    fullname: Han
– ident: ref_31
  doi: 10.3390/v13081570
– volume: 16
  start-page: 2389
  year: 2020
  ident: ref_4
  article-title: Recent advances of oncolytic virus in cancer therapy
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2020.1723363
  contributor:
    fullname: Mondal
– volume: 7
  start-page: 106
  year: 2017
  ident: ref_10
  article-title: Immune System, Friend or Foe of Oncolytic Virotherapy?
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2017.00106
  contributor:
    fullname: Filley
– volume: 379
  start-page: 150
  year: 2018
  ident: ref_9
  article-title: Recurrent Glioblastoma Treated with Recombinant Poliovirus
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1716435
  contributor:
    fullname: Desjardins
– ident: ref_7
  doi: 10.3390/cancers13061383
– ident: ref_16
  doi: 10.3390/v13081450
– volume: 8
  start-page: 958
  year: 2008
  ident: ref_32
  article-title: Exploring the full spectrum of macrophage activation
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2448
  contributor:
    fullname: Mosser
– volume: 5
  start-page: 755
  year: 2006
  ident: ref_33
  article-title: Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-05-0334
  contributor:
    fullname: Komarova
– volume: 115
  start-page: 4927
  year: 2018
  ident: ref_20
  article-title: Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1715295115
  contributor:
    fullname: Kim
– volume: 2020
  start-page: 438
  year: 2020
  ident: ref_11
  article-title: Modeling dynamics of cancer virotherapy with immune response
  publication-title: Adv. Differ. Equ.
  doi: 10.1186/s13662-020-02893-6
  contributor:
    fullname: Simbawa
– volume: 11
  start-page: 683
  year: 2020
  ident: ref_12
  article-title: Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.00683
  contributor:
    fullname: Shi
– volume: 17
  start-page: 349
  year: 2020
  ident: ref_15
  article-title: Oncolytic Viruses and the Immune System: The Dynamic Duo
  publication-title: Mol. Ther. Methods Clin. Dev.
  doi: 10.1016/j.omtm.2020.01.001
  contributor:
    fullname: Franco
– volume: 18
  start-page: 1827
  year: 2012
  ident: ref_17
  article-title: NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
  publication-title: Nat. Med.
  doi: 10.1038/nm.3013
  contributor:
    fullname: Yu
– volume: 14
  start-page: 153
  year: 2003
  ident: ref_25
  article-title: Gene therapy for killing p53-negative cancer cells: Use of replicating versus nonreplicating agents
  publication-title: Hum. Gene Ther.
  doi: 10.1089/104303403321070847
  contributor:
    fullname: Wodarz
– volume: 20
  start-page: 749
  year: 2012
  ident: ref_1
  article-title: The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2011.276
  contributor:
    fullname: Parato
– volume: 10
  start-page: 702
  year: 2020
  ident: ref_8
  article-title: Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2020.00702
  contributor:
    fullname: Gesundheit
– ident: ref_3
  doi: 10.1016/j.semcancer.2021.05.013
– volume: 83
  start-page: 75
  year: 2021
  ident: ref_26
  article-title: Natural Killer Cells Recruitment in Oncolytic Virotherapy: A Mathematical Model
  publication-title: Bull. Math. Biol.
  doi: 10.1007/s11538-021-00903-6
  contributor:
    fullname: Senekal
– volume: 65
  start-page: 2832
  year: 2005
  ident: ref_28
  article-title: An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-3227
  contributor:
    fullname: Kambara
– volume: 16
  start-page: 289
  year: 2020
  ident: ref_13
  article-title: NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
  publication-title: Mol. Ther. Oncolytics
  doi: 10.1016/j.omto.2020.02.001
  contributor:
    fullname: Leung
– volume: 66
  start-page: 2314
  year: 2006
  ident: ref_27
  article-title: Glioma virotherapy: Effects of innate immune suppression and increased viral replication capacity
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-2661
  contributor:
    fullname: Friedman
– ident: ref_6
  doi: 10.3390/cancers10100356
– volume: 23
  start-page: 239
  year: 2017
  ident: ref_14
  article-title: The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-0477
  contributor:
    fullname: Li
SSID ssj0000913849
Score 2.275737
Snippet Oncolytic virotherapy (OV) is a cancer therapy utilizing lytic viruses that specifically target cancer cells for elimination. In this relatively new therapy,...
SourceID doaj
proquest
gale
crossref
SourceType Open Website
Aggregation Database
StartPage 3370
SubjectTerms Adenoviruses
Anticancer properties
bifurcation
Cancer
Cancer therapies
Cell death
dynamical system
Equilibrium
Exact solutions
Food science
Immune system
Immunotherapy
Killer cells
mathematical model
Mathematical models
Mathematical research
NK cells
oncolytic virotherapy
Poliomyelitis
Population
Stability analysis
Therapy
Viral infections
Viruses
SummonAdditionalLinks – databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI_g9gIPaHyJYxvKA4inam2TNAkv6G7aNIF2Q4ihvUWJk8Kkrbddbw_899i93G17gNfGaio7dmzX_pmx9zXUEtpQFQakLGQAVViwZZHQG0lCe2ksdSOfzJrjM_nlXJ3nhFufyyrXNnEw1HEOlCPfr9GxVxhRVeXn65uCpkbR39U8QuMx26oxUqhHbGt6OPv2fZNlIdRLI-2q4l1gfL-PfuBvQqkSguYT37uLBsj-fxnm4bY52mbPspvIJyu5PmePUveCPT3ZYKz2L5lDCfNT1PgrJJxShSIknsuu-GmHAv6DhPznxeK2Tz33XeQzP6Bs8K9DAyA_SJeX_Sc-4XfvpT0zyvgrdnZ0-OPguMjjEgqQQi4LL3yIUWP8VVvlG9DRAhgIqSyjNrHVTasUBFWGJlTotQQVlUiiTlbbqDFSfc1G3bxLbxgXrbYNtAmUihKkt-hmGBOMkV6Cj2bMPqwZ565XqBgOowlisLvP4DGbElc3NIRlPTyYL365rBpOQds0wWuNRluGZE2Kxouq9U3ZVsFXY_aRZOJI45YLDz43DuCnEnaVm2gCLRTK4na7DyhRU-Dh8lqqLmtq7-7O1dv_L--wJzW1Pgz1ZbtstFzcpj10SJbhXT51fwF6--Cj
  priority: 102
  providerName: ProQuest
Title The Optimal Balance between Oncolytic Viruses and Natural Killer Cells: A Mathematical Approach
URI https://www.proquest.com/docview/2716571310
https://doaj.org/article/5cf66ba771464be98ed8a31fa60f1ba1
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09b9swECVSZ2mHIv1C3TgGhwadhEgiKZLZbCOOkcBOUDRFNoI8UmiBRCkse-i_z1GSE3soumSVDiJxT0feA-7eEfI1h5xD6bJEAecJdyASDTpNAmYjgUnLlY7dyPNFMbvhF7fidmvUV6wJa-WBW8edCCiLwlkpMaS5C1oFryzLSlukZeZsS3xSvUWmmjNYZ0xx3Va6M-T1J5j__YrqVIzFucRbd1Aj1f-vA7m5ZaYH5G2XHtJRu613ZC9U78mb-ZO2av2BGESWXmGk36PhOFYmQqBduRW9qhDYv2hIf_5erutQU1t5urCNuga9bBr_6CTc3dWndESfvxvX7NTFP5Kb6dmPySzpxiQkwBlfJZZZ571E3pVrYQuQXgMocCFNvVS-lEUpBDiRusJlmK044QULLA9aai-RoX4iveqhCp8JZaXUBZQBhPAcuNWYXijllOKWg_WqT443jjN_WjUMgywiOthsO7hPxtGrTzZRw7p5gMiaDlnzP2T75FvExMRIWy0t2K5hALcaNavMSEaxQiY0LjfYscQIgd3XG1RNF6G1yZEoCmToWfrlJTZ7SF7nsTGiqT4bkN5quQ5HmK6s3JC8UtPzIdkfny2uvw-b__QR6T7rLw
link.rule.ids 315,783,787,867,2109,12779,21402,27938,27939,33387,33758,43614,43819,74371,74638
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagHIAD4ikWCvgA4hQ1ie3Y5oK2FctCu9tLi3qz7LEDSCVbNtsD_56ZrHfbHuAaj-JoxvNyZr5h7G0NtYQ2VIUBKQsZQBUWbFkkjEaS0F4aS93Is3kzPZVfz9RZvnDrc1nlxiYOhjougO7I92oM7BVmVFX58eJ3QVOj6O9qHqFxm92RAh0NdYpPPm_vWAjz0ki7rncXmN3vYRT4gzCqhKDpxNc80QDY_y-zPPiayUP2IAeJfLyW6iN2K3WP2f3ZFmG1f8Icypcfo77_QsJ9qk-ExHPRFT_uULx_kJB_-7m87FPPfRf53A8YG_xwaP_jB-n8vP_Ax_zqvbRnxhh_yk4nn04OpkUellCAFHJVeOFDjBqzr9oq34COFsBASGUZtYmtblqlIKgyNKHCmCWoqEQSdbLaRo156jO20y269Jxx0WrbQJtAqShBeotBhjHBGOkl-GhG7N2Gce5ijYnhMJcgBrvrDB6xfeLqloaQrIcHi-V3lxXDKWibJnit0WTLkKxJ0XhRtb4p2yr4asTek0wc6dtq6cHntgH8VEKucmNNkIVCWdxu9wYl6gncXN5I1WU97d3VqXrx_-U37O70ZHbkjr7MD1-yezU1QQyVZrtsZ7W8TK8wNFmF18P5-wtlfOIu
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELYglRAcEE81tIAPIE6r7K7ttc0FJaVRoTStEEW9WfbYBqSyabPpgX_PeOOk7QGu69F6NS_PeGe-IeRNDTWH6KpCAecFdyAKDbosAkYjgUnLlU7dyEez5uCUfz4TZ7n-qctllWuf2DtqP4d0Rz6qMbAXmFFV5SjmsoiTj9MPF5dFmiCV_rTmcRp3yZbkqFUDsjXZn5183dy4JARMxfWq-p1hrj_CmPBnQqxiLM0qvnEu9fD9_3LS_ckzfUQe5pCRjlcyfkzuhPYJeXC0wVvtnhKD0qbHaP2_kXCSqhUh0FyCRY9bFPYfJKTffy2uutBR23o6sz3iBj3smwHpXjg_797TMb1-b9ozI44_I6fT_W97B0UenVAAZ3xZWGad9xJzsVoL24D0GkCBC2XppfJRNlEIcKJ0jaswgnHCCxZYHbTUXmLW-pwM2nkbtgllUeoGYgAhPAduNYYcSjmluOVgvRqSt2vGmYsVQobBzCIx2Nxk8JBMElc3NAnXun8wX_ww2UyMgNg0zkqJDpy7oFXwyrIq2qaMlbPVkLxLMjHJ-pYLCzY3EeCnJhwrM5YJwJAJjdvt3qJEq4Hby2upmmy1nbnWsRf_X35N7qHymS-fZoc75H6dOiL6srNdMlgursJLjFOW7lVWwL_XoefR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Optimal+Balance+between+Oncolytic+Viruses+and+Natural+Killer+Cells%3A+A+Mathematical+Approach&rft.jtitle=Mathematics+%28Basel%29&rft.au=Dongwook+Kim&rft.au=Dong-Hoon+Shin&rft.au=Chang+K.+Sung&rft.date=2022-09-01&rft.pub=MDPI+AG&rft.eissn=2227-7390&rft.volume=10&rft.issue=18&rft.spage=3370&rft_id=info:doi/10.3390%2Fmath10183370&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_5cf66ba771464be98ed8a31fa60f1ba1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2227-7390&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2227-7390&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2227-7390&client=summon